About Levikas
Levikas is a Healthcare company based in Delhi (India) founded in 2021. It serves as a pharmaceutical distributor with an online portal for convenient product purchases. It operates on a B2B model. Its Indian entity Levikas Enterprises Private Limited reported revenue of ₹57.07 Cr. Its focus areas include Pharmaceuticals, Distribution and Online Sales. Similar companies include AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales and 1 more; 3 of its 6 listed similar companies have raised funding.
Company details
Levikas, established in 2021, excels in providing healthcare solutions, producing pharmaceutical products, distribution, and conducting sales online. Serves as a pharmaceutical distributor with an online portal for convenient product purchases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Delhi, India
- SectorsHealthcare
- Website levikas.com
- Legal Name Levikas Enterprises Private Limited
- Date of Incorporation 25 Jun, 2019
- Jurisdiction Delhi, India
- Annual Revenue₹57.07 Cr
FY 2025 · +33% YoY
- Net Loss-₹23.8 Lakh
FY 2025 · 0% margin
- EBITDA₹42.3 Lakh
FY 2025 · 1% margin
Associated legal entities of Levikas
Levikas operates through Levikas Enterprises Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Levikas Enterprises Private Limited CIN U33119DL2019PTC351808 | Active | 25 Jun 2019 | Delhi, Delhi | ₹57.1 Cr | – | 2 | View details |
Board of directors of Levikas Enterprises Private Limited (Levikas)
Levikas Enterprises Private Limited is the primary company behind Levikas. The board of Levikas Enterprises Private Limited currently have 2 directors; the longest-serving is Veerinder Pal Singh, appointed in 2022. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Veerinder Pal Singh DIN 02241954 | Director | 16 May 2022 | 4 yrs 5 mo | Levikas Enterprises Private Limited |
| Harsharan Kaur DIN 02253033 | Director | 16 May 2022 | 4 yrs 5 mo | Levikas Enterprises Private Limited |
Financials of Levikas
Figures of Levikas Enterprises Private Limited, the primary company behind Levikas, for FY 2025. Revenue was ₹57.07 Cr (+33% year on year). Net loss was -₹23.8 Lakh (0% margin). EBITDA was ₹42.3 Lakh (1% margin). Revenue has grown at a compounded annual rate of +56% over three years.
- ₹57.07 CrRevenue · FY 2025 · +33% YoY
- -₹23.8 LakhNet loss · 0% margin
- ₹42.3 LakhEBITDA · 1% margin
- ₹1 LakhPaid-up capital
- +56%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Levikas Enterprises Private Limited are on its company page.
Detailed financial statements for Levikas
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Levikas
Levikas has 6 listed similar companies in our database, 3 of them funded. They include AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed similar companies of Levikas
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Levikas (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Levikas
Levikas was founded in 2021.
Levikas is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Levikas, Levikas Enterprises Private Limited, reported revenue of ₹57.07 Cr for FY 2025, up 33% year on year.
Levikas, established in 2021, excels in providing healthcare solutions, producing pharmaceutical products, distribution, and conducting sales online. Serves as a pharmaceutical distributor with an online portal for convenient product purchases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Levikas's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Levikas operates through Levikas Enterprises Private Limited.
The legal entities of Levikas currently have 2 directors, including Veerinder Pal Singh, Harsharan Kaur.